Topic: The New England Journal Of Medicine
NEW YORK (Reuters Health) - Devices to restore a normal heartbeat after cardiac arrest appear to be less useful at home than in public places, researchers said Wednesday.The so-called automatic external defibrillators, or AEDs, are already present in airports and casinos across ...
Medicare publicly reports each hospital's death and readmission rates for patients with several conditions. At the recent American Heart Association meeting in Chicago, two studies of patients with heart failure provided a striking negative verdict on remote monitoring. First, a study from ...
Medicare publicly reports each hospital's death and readmission rates for patients with several conditions. At the recent American Heart Association meeting in Chicago, two studies of patients with heart failure provided a striking negative verdict on remote monitoring. First, a study from ...
This was the case in November when an international team of cardiovascular researchers realized the lifesaving potential of the drug ramipril (Altace) for a broad array of patients at high risk for heart attack, stroke, or death from cardiovascular causes. ) Because ...
Researchers found that even those with normal or low blood pressure should watch the amount of salt in their diet. According to a doctor of the Indiana University School of Medicine, you have a higher risk of developing heart disease if you ...
Confirm your Subscription | Having trouble viewing this e-mail click here | To unsubscribe click here. October 8, 2010 The majority of patients undergoing coronary revascularization are likely to have a stress test in the following two years, with relatively few requiring ...
The adenosine A1-receptor antagonist rolofylline does not appear beneficial in treating acute heart failure patients with renal dysfunction, according to research published in the Oct. 7 issue of the New England Journal of Medicine. Barry M. Massie, M.D., of the University of ...
Confirm your Subscription | Having trouble viewing this e-mail click here | To unsubscribe click here. September 22, 2010 Fondaparinux appears to be safe and effective for reducing symptomatic superficial-vein thrombosis of the legs and may reduce the risk of that condition ...
Two studies, published online Aug. 29 in The Lancet to coincide with the European Society of Cardiology Congress, held from Aug. 28 to Sept. 1 in Stockholm, Sweden, support the association of certain genetic variants with reduced efficacy of clopidogrel; however, they ...
Coronary everolimus-eluting stents result in superior clinical outcomes compared with paclitaxel-eluting stents, and reduced rates of target-lesion failure at one year seen with everolimus-eluting stents are consistent in all patients except those with diabetes, according to research published in the May 6 ...
Photo Gallery
From Around the Web
Video Gallery
-
The New England Journal of Medicine ...
A brief video introducing the redesigned NEJM.org with commentary ...2010-07-29 -
New England Journal of Medicine Article- ...
Brief critique of the 2000 Cherkin and Deyo article comparing ...2009-12-06 -
New England Journal of Medicine Publishes ...
Sound Bites: Dr. Kevin Ault, Emory University School of Medicine2007-05-09
